147 results on '"Cirilli, N."'
Search Results
2. P466 Yoga in children with cystic fibrosis: complementary therapy alternative to the yoga practice in the presence
3. P477 How the use of nocturnal non-invasive ventilation and oxygen therapy changes in patients with cystic fibrosis using elexacaftor/tezacaftor/ivacaftor
4. P348 Nutritional challenges in the era of cystic fibrosis transmembrane regulator modulators: can we still trust the body mass index?
5. P017 Sweat test: different clinical questions require different lab reports
6. Real life practice of sweat testing in Europe
7. P413 How to use telemonitoring for the detection of respiratory exacerbations in cystic fibrosis: effectiveness and adherence
8. P040 Sweat chloride values in cystic fibrosis patients after one year on elexacaftor/tezacaftor/ivacaftor
9. A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis
10. P129 Evidence for a role of Achromobacter xylosoxidans VBNC forms in chronic cystic fibrosis lung infection
11. P162 Body composition assessment in cystic fibrosis (CF) patients on elexacaftor/texacaftor/ivacaftor
12. P207 Spirometric values and 6-minute walking distance in cystic fibrosis patients on elexacaftor/texacaftor/ivacaftor
13. P113 Microbiology assessment in cystic fibrosis patients on elexacaftor/tezacaftor/ivacaftor
14. P032 Sweat chloride values in cystic fibrosis patients on elexacaftor/tezacaftor/ivacaftor
15. Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme
16. [Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020]
17. Italian cystic fibrosis registry (ICFR): Report 2017-2018
18. CYSTIC FIBROSIS NEWBORN SCREENING IN ITALY: EDUCATIONAL ASPECT: 442
19. P020 CFTR mutation panel in detecting cystic fibrosis screen positive inconclusive diagnosis patients (CFSPIDs) in the Marche Region, Italy
20. P007 A novel cystic fibrosis-causing mutation identified in a newborn of African origin
21. ORAL DHA SUPPLEMENTATION IN CHILDREN WITH CF: A RANDOMIZED PLACEBO-CONTROLLED STUDY: 499
22. P029 Validation of new sweat test control materials
23. P005 Lessons from 5T;TG12
24. METHICILLIN-RESISTANT S. AUREUS (MRSA) IN CYSTIC FIBROSIS PATIENTS: PREVALENCE AND CLINICAL FINDINGS: 397
25. Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016
26. P278 Cataloguing outcome measures of cystic fibrosis clinical studies
27. Italian Cystic Fibrosis Registry. Report 2011-2014
28. Intra-individual biological variation in sweat chloride concentrations
29. Italian Cystic Fibrosis Register - Report 2010
30. 111 Non-tuberculous mycobacteria in patients with cystic fibrosis: detection and isolation from respiratory samples. Results of a cross-sectional study
31. WS10.6 Intra-individual biological variation in sweat chloride concentrations
32. 428 Are cystic fibrosis guidelines credible? Evaluating methodological issues
33. Mutazioni nei geni del pathway pancreatico: fattore di rischio per pancreatite in pazienti con fibrosi cistica?
34. Intra-individual biological variation in sweat chloride concentrations
35. WS11.4 Real life practice of sweat testing in Europe: results from an ECFS-wide survey
36. 62 Molecular diagnosis of Pseudomonas aeruginosa infection in culture-negative samples from cystic fibrosis patients
37. 282 Patient priorities for research in cystic fibrosis: the IPaCOR experience
38. 26 Risk factors for poor outcomes in cystic fibrosis newborns diagnosed by neonatal screening in Italy: years 2009–2011
39. 281 Patient-centered outcomes in CF research
40. 10 The role of complex alleles in patients with cystic fibrosis and L997F
41. WS21.3 Clinical variability in patients with cystic fibrosis and D1152H mutation
42. 20 Cystic fibrosis newborn screening in Italy: survey for assessment of technical-scientific and organizational issues
43. 290 Oral DHA supplementation in children with cystic fibrosis: a randomized placebo-controlled study
44. EMERGENCE OF COLISTIN-RESISTANT PSEUDOMONAS AERUGINOSA FROM ITALIAN CYSTIC FIBROSIS PATIENTS
45. Pseudomonas aeruginosa (PA) resistant to colistin (CL) in Italian cystic fibrosis (CF) patients
46. 110 Genetic fingerprinting of Pseudomonas aeruginosa (PA) from Italian CF patients (pts): comparison with isolates from environment and other clinical origins in Europe
47. 73* Occurrence of P. aeruginosa (PA) with hypermutable phenotype (HPM) in Italian CF patients
48. Italian cystic fibrosis register report 2010,Registro Italiano fibrosi cistica rapporto 2010
49. Italian cystic fibrosis registry report 2011-2014,Registro Italiano Fibrosi cistica Rapporto 2011-2014
50. Sweat testing: Recommendations for the performance and interpretation of results of the Italian cystic fibrosis society,Il test del sudore. Raccomandazioni per una corretta esecuzione e interpretazione dei risultati
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.